Page last updated: 2024-10-22

amsacrine and Atypical Chronic Myeloid Leukemia

amsacrine has been researched along with Atypical Chronic Myeloid Leukemia in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research Excerpts

ExcerptRelevanceReference
"Four had an antecedent chronic phase of chronic myelogenous leukemia and 15 presented with ALL."1.28Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL. ( Ahmed, T; Arlin, ZA; Feldman, EJ; Liebowitz, D; Shapiro, LR; Wilmot, PL, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlin, ZA1
Feldman, EJ1
Ahmed, T1
Liebowitz, D1
Shapiro, LR1
Wilmot, PL1

Other Studies

1 other study available for amsacrine and Atypical Chronic Myeloid Leukemia

ArticleYear
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL.
    Acta haematologica, 1989, Volume: 81, Issue:4

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evalu

1989